Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
doi: https://doi.org/10.1101/2020.11.09.20228551
Peter Kremsner
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
10German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany
11Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
Philipp Mann
6Curevac AG, Frankfurt, Germany
Jacobus Bosch
5Hannover Medical School (MHH), Hannover, Germany
Rolf Fendel
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
Julian J. Gabor
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
Andrea Kreidenweiss
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
Arne Kroidl
3Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany
4German Center for Infection Research (DZIF), partner site Munich, Germany
Isabel Leroux-Roels
2Ghent University Hospital, Ghent, Belgium
Geert Leroux-Roels
2Ghent University Hospital, Ghent, Belgium
Christoph Schindler
5Hannover Medical School (MHH), Hannover, Germany
Mirjam Schunk
3Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany
4German Center for Infection Research (DZIF), partner site Munich, Germany
Thirumalaisamy P. Velavan
1Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany
Mariola Fotin-Mleczek
9Curevac AG, Tübingen, Germany
Stefan Müller
6Curevac AG, Frankfurt, Germany
Gianluca Quintini
8Cogitars, Heidelberg, Germany
Oliver Schönborn-Kellenberger
8Cogitars, Heidelberg, Germany
Dominik Vahrenhorst
9Curevac AG, Tübingen, Germany
Thomas Verstraeten
7P95 Epidemiology and Pharmacovigilance, Leuven, Belgium
Lisa Walz
6Curevac AG, Frankfurt, Germany
Olaf-Oliver Wolz
9Curevac AG, Tübingen, Germany
Lidia Oostvogels
6Curevac AG, Frankfurt, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted November 09, 2020.
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
medRxiv 2020.11.09.20228551; doi: https://doi.org/10.1101/2020.11.09.20228551
Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers
Peter Kremsner, Philipp Mann, Jacobus Bosch, Rolf Fendel, Julian J. Gabor, Andrea Kreidenweiss, Arne Kroidl, Isabel Leroux-Roels, Geert Leroux-Roels, Christoph Schindler, Mirjam Schunk, Thirumalaisamy P. Velavan, Mariola Fotin-Mleczek, Stefan Müller, Gianluca Quintini, Oliver Schönborn-Kellenberger, Dominik Vahrenhorst, Thomas Verstraeten, Lisa Walz, Olaf-Oliver Wolz, Lidia Oostvogels
medRxiv 2020.11.09.20228551; doi: https://doi.org/10.1101/2020.11.09.20228551
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (442)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)